As with many infectious epidemics, household contacts, first responders, care givers, and medical personnel attending to persons with COVID-19 have a high risk of infection. PEP is defined as taking antimicrobial medication after potential exposure to an infectious agent to prevent becoming infected. The COVID-19 PEP Study is trying to answer: does hydroxychloroquine (HCQ) work to prevent people getting COVID-19 when taken by people who have had recent exposure to someone with the virus? We’re on a mission to answer that. Our findings are changing our understanding of how PEP could prevent COVID-19 among those most at risk.
Read the study launch announcement here: https://globalhealth.washington.edu/news/2020/03/30/does-antimalarial-drug-prevent-covid-19-new-dgh-study-seeks-answers